Omeprazol-Mepha 40 mg, magensaftresistente Kapseln

7680628750384 CH-62875 Magensaftresistente Kapseln

Associated product:

OMEPRAZOL Mepha caps 40 mg bte 7 pce
Omeprazol-Mepha 40 mg, magensaftresistente Kapseln
Omeprazol-Mepha 40 mg, magensaftresistente Kapseln
Omeprazol-Mepha 40 mg, magensaftresistente Kapseln
1 / 3
google

Article details

Package size
7
Selling units
7
Measure
Kapsel(n)
Galenic form
Magensaftresistente Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/07/2024
Patient information leaflet
Français
16/07/2024
Patient information leaflet
Italien
16/07/2024
Summary of Product Characteristics
Allemand
16/07/2024
Summary of Product Characteristics
Français
16/07/2024
Summary of Product Characteristics
Italien
16/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
160.05 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
3.03 MG Substance HBESI

Reimbursement information

Public price
CHF 14.50
Specialties list
Yes
Generic
Yes
SL addition date: 01/01/2015

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
62875
Drug name
Omeprazol-Mepha, magensaftresistente Kapseln
Galenic form
KAHAM
ATC Code
A02BC01
Authorization status
Z
Dispensing category
B
First authorization
20/11/2013
Authorization expiration date
31/12/9999
IT Number
04.99.0.
Domain
Human medicine
Field of application
Ulcustherapie, Zollinger-Ellison-Syndrom

Package details

Description (FR)
OMEPRAZOL Mepha caps 40 mg bte 7 pce
Description (DE)
OMEPRAZOL Mepha Kaps 40 mg Ds 7 Stk
Market launch
20/11/2013
Narcotic (BTM)
No

Original drug

Antramups, Tabletten
GTIN: 7680543800386
CHF 16.20
View original

Other package sizes (10)

None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
OMEPRAZOL Mepha caps 10 mg bte 14 pce
14 KAP
GTIN: 7680628750292
View
OMEPRAZOL Mepha caps 10 mg bte 28 pce
28 KAP
GTIN: 7680628750308
View
OMEPRAZOL Mepha caps 10 mg bte 56 pce
56 KAP
GTIN: 7680628750315
View
OMEPRAZOL Mepha caps 10 mg bte 98 pce
98 KAP
GTIN: 7680628750322
View
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1